Trinity Biotech regains compliance with Nasdaq
TRIB Stock | USD 1.12 0.01 0.88% |
About 62% of Trinity Biotech's investor base is looking to short. The analysis of overall sentiment of trading Trinity Biotech plc stock suggests that many investors are alarmed at this time. The current market sentiment, together with Trinity Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Trinity Biotech plc stock news signals to limit their universe of possible portfolio assets.
Trinity |
Trinity Biotech regains compliance with Nasdaqs market value of publicly held shares requirement.
Read at seekingalpha.com
Trinity Biotech Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Trinity Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Trinity Biotech Fundamental Analysis
We analyze Trinity Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trinity Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trinity Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Trinity Biotech is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Trinity Biotech plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Trinity Biotech stock to make a market-neutral strategy. Peer analysis of Trinity Biotech could also be used in its relative valuation, which is a method of valuing Trinity Biotech by comparing valuation metrics with similar companies.
Peers
Trinity Biotech Related Equities
NOTV | Inotiv | 10.97 | ||||
LAB | Standard Biotools | 6.43 | ||||
ACRS | Aclaris Therapeutics | 5.23 | ||||
NDRA | ENDRA Life | 3.60 | ||||
SERA | Sera Prognostics | 2.80 | ||||
STIM | Neuronetics | 1.37 | ||||
SHC | Sotera Health | 1.16 | ||||
MDXH | MDxHealth | 1.03 | ||||
BDSX | Biodesix | 0.00 | ||||
FONR | Fonar | 0.36 | ||||
CSTL | Castle Biosciences | 0.43 | ||||
PRE | Prenetics Global | 1.56 | ||||
STRRP | Star Equity | 1.77 | ||||
XGN | Exagen | 2.54 |
Complementary Tools for Trinity Stock analysis
When running Trinity Biotech's price analysis, check to measure Trinity Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Biotech is operating at the current time. Most of Trinity Biotech's value examination focuses on studying past and present price action to predict the probability of Trinity Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trinity Biotech's price. Additionally, you may evaluate how the addition of Trinity Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |